Clinical
Concern over rising triple-therapy use
New report shows 130% increase in use of triple therapy for COPD, as well as a 31% drop in spirometry testing rates Patients with COPD who are using triple therapy …
New pack size to ‘help address supply shortage’
PBAC recommends expanding empagliflozin treatment population in line with “pivotal” trial, changes to max quantities for pioglitazone and listing of new contraceptive choice in May meeting The PBAC has recommended …
RSV vax decision deferred
NIP listing proposal for immunising infants and young children temporarily knocked back for legislative reasons A decision on the proposed NIP listing of respiratory syncytial virus (RSV) vaccine nirsevimab (Beyfortus) …
June MIMS update
Some of the recent changes to the medicines landscape, with new products, indications, contraindications and presentations New Products Lazertinib (as mesilate monohydrate) (Lazcluze) is a third generation, epidermal growth factor …
Biosimilars: costs and administrative burden are stopping uptake
A new industry report calls for measures to improve access to biosimilar medicines in Australia The level of uptake of biosimilar medicines in Australia is well below the average across …
Mixed news on medicines scheduling
Regulators confirm that no change is to be made to astrodrimer sodium gel scheduling despite opposition from leading pharmacy groups. However another change is confirmed The Therapeutic Goods Administration’s Advisory …
Therapeutic need reminder on vaping
A pharmacist allegedly supplied therapeutic vaping products without adequately confirming that it was clinically appropriate to do so, the Board says In its latest newsletter, the Pharmacy Board has drawn …
Penicillin allergy: separating the true from the false
A team of Monash University researchers have successfully piloted an algorithm to identify incorrect penicillin allergy labels and educate patients presenting to community pharmacies Patients are often inappropriately labelled as …
Risperidone: take extra care
The TGA has been receiving increased reports of paediatric dosing error with risperidone “We received 22 adverse event reports in 2024 involving the overdose of risperidone oral solution in Australian …
TGA issues updated warnings for RSV vaccines
Safety information for two RSV vaccines is being updated to “reflect the low risk of people contracting Guillain-Barre syndrome following vaccination Immunisers are being advised to be aware of the …
May MIMS update
Some of the recent changes to the medicines landscape, with new products, indications, contraindications, presentations and safety related changes New Products Dexrazoxane (Dexrazoxane-Reach) is an analogue of ethylene diamine tetra-acetic …
Palliative project to support stakeholders
Access to core palliative care medicines needed for people receiving end-of-life care The Pharmaceutical Society of Australia (PSA) has joined up as part of a new consortium led by Palliative …